论文部分内容阅读
目的观察比较A群链球菌制剂和平阳霉素制剂注射治疗颌面血管瘤和脉管畸形的治疗效果。方法 81例颌面血管瘤和脉管畸形病例,分别采用A群链球菌制剂和平阳霉素制剂注射治疗,记录其疗效和毒副作用,并对所有病例进行随访。结果血管瘤21例:A群链球菌制剂组10例,治愈5例(50.0%),平阳霉素组11例,治愈6例(54.55%);静脉畸形30例:A群链球菌制剂组14例,治愈8例(57.14%),平阳霉素组12例,治愈7例(58.33%);淋巴管畸形30例:A群链球菌制剂组17例,治愈13例(76.47%),平阳霉素组13例,治愈5例(38.46%)。结论颌面血管瘤和静脉畸形患者A群链球菌制剂和平阳霉素制剂注射治疗均有效,淋巴管畸形患者A群链球菌制剂疗效明显优于平阳霉素制剂注射。
Objective To compare the therapeutic effects of injecting A group and Pingyangmycin in the treatment of maxillofacial hemangiomas and vascular malformations. Methods A total of 81 cases of maxillofacial hemangiomas and vascular malformations were treated with Group A streptococcal and pingyangmycin injection respectively. The curative effect and side effect were recorded and all the cases were followed up. Results 21 cases of hemangiomas: 10 cases of group A streptococcus preparation, 5 cases (50.0%) were cured, 11 cases were treated with pingyangmycin, 6 cases were cured (54.55%), 30 cases were group A streptococcus Among them, 8 cases were cured (57.14%), 12 cases were treated with Pingyangmycin, 7 cases were cured (58.33%), 30 cases were lymphatic malformations, 17 cases were group A streptococcus (13 cases, 76.47% Sup group of 13 cases, 5 cases were cured (38.46%). Conclusion The treatment of maxillofacial hemangiomas and venous malformations in Group A streptococcal and bleomycin preparations is effective. The efficacy of group A streptococcal lymphatic malformations is superior to that of bleomycin.